According to a new report Global Sleep Apnea Devices Market, published by KBV research, The Global Sleep Apnea Devices Market size is expected to reach $8.8 billion by 2025, rising at a market growth of 7.2% CAGR during the forecast period.

The therapeutic devices product type segment dominated the market in 2019 due to increased patient understanding of disease, availability of technologically advanced products, and increased competition on the market. The diagnostic device segment has been estimated to experience a lucrative growth rate over the forecast period.

The diagnostic device section comprises a range of devices, such as respiratory polygraphs, actigraphs, pulse oximeters, and polysomnography. The most widely used measures for the diagnosis of obstructive sleep apnea are the polysomnography tests. In addition, respiratory polygraphs are commonly used to treat home conditions for the sleep apnea. Respiratory polygraphs are considered a replacement for polysomnography; thus, their affordability among patients has increased its acceptance. Increasing awareness and increase in the number of patients diagnosed with respiratory disorders are some of the factors responsible for driving growth of the segment over the forecast period.

North America recorded a leading market share in the regional segment. Growing recognition of sleep apnea, large patient pool and the involvement of international manufacturers are expected to increase this region's market share. On the other hand, the Asia Pacific region is projected to expand at the fastest growth rate over the forecast period. The emergence of a large undiagnosed patient pool and rising investment in healthcare infrastructure are expected to drive growth in the sector.

Structural Insights: https://www.kbvresearch.com/sleep-apnea-devices-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Koninklijke Philips N.V., Fisher & Paykel Healthcare Corporation Limited, SomnoMed Limited, Mitsui Chemical, Inc. (Whole You, Inc.), Teleflex, Inc., ResMed, Inc., Oventus Medical Ltd., Panthera Dental, Inc. (Panthera Sleep), BRAEBON Medical Corporation, and BMC Medical Co., Ltd.

Global Sleep Apnea Devices Market Segmentation

By Product Type
• Therapeutic Devices and
• Diagnostic Devices

By Therapeutic Devices Type
• PAP Devices
• Oral Devices
• Nasal Devices and
• Chin Straps

By Diagnostic Devices Type
• Polysomnography
• Respiratory Polygraphs
• Pulse Oximeters and
• Actigraphs

By Geography

North America
• US
• Canada
• Mexico
• Rest of North America

Europe
• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

LAMEA
• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled
• Koninklijke Philips N.V.
• Fisher & Paykel Healthcare Corporation Limited
• SomnoMed Limited
• Mitsui Chemical, Inc. (Whole You, Inc.)
• Teleflex, Inc.
• ResMed, Inc.
• Oventus Medical Ltd.
• Panthera Dental, Inc. (Panthera Sleep)
• BRAEBON Medical Corporation
• BMC Medical Co., Ltd.